Document is current
Any future updates will be listed below
-
Authors
d’Otreppe, Stéphanie https://orcid.org/0000-0003-4578-5131
Lefèvre, Philippe
Meex, Cécile https://orcid.org/0000-0002-2499-2038
Devey, Anaïs https://orcid.org/0000-0001-9628-3954
Sacheli, Rosalie https://orcid.org/0000-0002-3922-324X
Gerard, Martin
Melin, Pierrette https://orcid.org/0000-0002-2159-5774
- License Information
-
More Information
Article History
Accepted: 28 May 2023
First Online: 20 July 2023
Declarations
:
: Study performed with the support of GenePOC for the provision of the Revogene<sup>®</sup> instruments and Revogene<sup>®</sup> GBS DS kits.
: Financial interests: PM has received travel support from GenePOC, Canada to participate at the ECCMID 2018. All the other authors have no relevant financial or non-financial interests to disclose.
: PM and CM conceived and designed the study. RS provided advice on the technical design of the study and interpretation of data. SDO organized, coordinated, and set up the multicenter study. SDO and AD acquired and analyzed the data. SDO drafted the manuscript. PM, PL, and MG revised the manuscript for its critically important content. All authors read and approved the final manuscript.
: The datasets generated and analyzed during the current study are available from the corresponding author upon reasonable request.
: The study protocol was approved by the Hospital-Faculty Ethical Committee of the University of Liège (Reference 2019/113).
: All women included in the study gave written informed consent.
: Not applicable.
: Not applicable.
